Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
An announcement from Oncolytics Biotech ( (ONCY) ) is now available.
Oncolytics Biotech shareholders approved all resolutions at a special meeting, backing the company’s plan to shift its corporate domicile from Alberta to British Columbia and then to Nevada, and to adopt a new 2026 Incentive Award Plan. The moves, expected to take effect by the end of the first quarter of 2026, are aimed at streamlining regulatory and operational processes and aligning corporate governance and incentive structures with U.S. capital markets, potentially enhancing the company’s flexibility in financing, talent retention, and strategic execution as it advances its immunotherapy pipeline.
The most recent analyst rating on (ONCY) stock is a Hold with a $0.96 price target. To see the full list of analyst forecasts on Oncolytics Biotech stock, see the ONCY Stock Forecast page.
Spark’s Take on ONCY Stock
According to Spark, TipRanks’ AI Analyst, ONCY is a Neutral.
The score is driven primarily by weak financial performance (no revenue, large losses, heavy cash burn) and heightened balance-sheet strain from sharply reduced equity. Technical indicators also point to a weak trend and bearish momentum. Valuation provides only limited support because the negative P/E reflects ongoing losses and there is no dividend yield provided.
To see Spark’s full report on ONCY stock, click here.
More about Oncolytics Biotech
Oncolytics Biotech Inc. is a clinical-stage biotechnology company focused on developing pelareorep, an investigational intravenously delivered double-stranded RNA immunotherapeutic agent. The drug is being advanced primarily in metastatic pancreatic and breast cancers, both of which have received Fast Track designation from the U.S. FDA, as well as in other gastrointestinal tumors, with the company pursuing strategic partnerships to accelerate development and commercial impact.
Average Trading Volume: 747,369
Technical Sentiment Signal: Sell
Current Market Cap: $113M
See more insights into ONCY stock on TipRanks’ Stock Analysis page.